SG Americas Securities’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.8M Buy
1,657,846
+280,199
+20% +$5.62M 0.03% 410
2025
Q4
$32.3M Buy
1,377,647
+220,264
+19% +$4.78M 0.04% 342
2025
Q3
$23.1M Buy
1,157,383
+8,302
+0.7% +$149K 0.08% 167
2025
Q2
$15.7M Buy
1,149,081
+986,567
+607% +$9.47M 0.07% 223
2025
Q1
$1.8M Buy
162,514
+142,245
+702% +$1.52M 0.01% 838
2024
Q4
$216K Buy
20,269
+6,207
+44% +$74.3K ﹤0.01% 2080
2024
Q3
$179K Buy
+14,062
New +$209K ﹤0.01% 2592
2024
Q1
Sell
-8,707
Closed -$131K 3466
2023
Q4
$131K Buy
+8,707
New +$113K ﹤0.01% 2530
2021
Q4
Sell
-10,318
Closed -$174K 3828
2021
Q3
$174K Buy
+10,318
New +$164K ﹤0.01% 3320
2021
Q2
Sell
-5,235
Closed -$102K 3263
2021
Q1
$102K Sell
5,235
-51,009
-91% -$1.08M ﹤0.01% 3077
2020
Q4
$1.01M Sell
56,244
-5,492
-9% -$115K 0.01% 1534
2020
Q3
$1.19M Sell
61,736
-69,914
-53% -$1.58M 0.01% 1076
2020
Q2
$3.44M Buy
131,650
+30,053
+30% +$734K 0.04% 522
2020
Q1
$1.81M Buy
101,597
+51,257
+102% +$1.38M 0.02% 865
2019
Q4
$1.68M Buy
50,340
+585
+1% +$16K 0.02% 934
2019
Q3
$1.19M Buy
+49,755
New +$1.63M 0.01% 1298

Other funds holding URGN